Table 7 Rates of recurrences in the literature
From: Giant cell tumor of tendon sheath in the hand: analysis of risk factors for recurrence in 50 cases
Paper | Total number of casesb | Cases with known risk factor | Recurrence rate in high risk cases | Overall recurrence rate (%) | Follow up (months) |
|---|---|---|---|---|---|
Wright (1951) [16] | 54 | a | a | 44 | 1–120 |
Sherry and Anderson (1955) [17] | 12 | a | a | 25 | 12–72 |
Jones (1969) [18] | 72 | 53 joint involvement | a | 22 | 1–120 |
Fyfe and MacFarlane (1980) [19] | 51 | 30 joint involvement | a | 38 | 6–240 |
Rao and Vigorita (1984) [20] | 17 | a | a | 29 | 3–108 |
Moore et al. (1984) [21] | 115 | 53 joint involvement, 10 bone involvement | a | 9 | 1–324 |
Grover et al. (1998) [22] | 52 | 7 bone involvement, 13 tumor was Al Qattan type 2 | 57% with bone involvement; 30% with Al Qattan type 2 | 15 | 7–174 |
Looi et al. (1999) [23] | 53 | 21 bone involvement | a | 7 | 12–60 |
Reilly et al. (1999) [8] | 70 | 10 bone involvement, 30 joint involvement | 50% with bone involvement; 42% with joint involvement, | 27 | 7–138 |
Kotwal et al. (2000) [13] | 48 | a | a | 4 | 24–132 |
Al-Qattan (2001) [5] | 43 | 13 tumor was Al Qattan type 2 | 38% with Al Qattan type 2 | 11 | 24–72 |
Ozalp et al. (2004) [24] | 134 | a | a | 16 | 6–132 |
Kigawa et al. (2004) [12] | 30 | 3 | a | 13 | 12–126 |
Lowyck and De Smet (2006) [25] | 43 | 27 joint involvement, 8 bone involvement | 0% with bone involvement; 14% with joint involvement | 16 | 15–136 |
Darwish (2008) [2] | 52 | a | a | 24 | 36–120 |
Williams et al. (2010) [10] | 213 | 10 bone involvement, 40 joint involvement, 23 neurovascular involvement | 10% with bone involvement; 30% with joint involvement, 22% with neurovascular involvement | 13 | 36-a |
Di Grazia et al. (2013) [4] | 64 | 7 neurovascular involvement | 42% with neurovascular involvement | 4.7 | 2–153 |
Koutserimpas et al. (2018) [6] | 36 | 9 tumor was Al Qattan type 2 | a | 11 | a |